Cargando…
Principles and Applications of CF(2)X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery
[Image: see text] As an orthogonal principle to the established (hetero)aryl halides, we herein highlight the usefulness of CF(2)X (X = Cl, Br, or I) moieties. Using tool compounds bearing CF(2)X moieties, we study their chemical/metabolic stability and their logP/solubility, as well as the role of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424184/ https://www.ncbi.nlm.nih.gov/pubmed/37487500 http://dx.doi.org/10.1021/acs.jmedchem.3c00634 |
_version_ | 1785089620001685504 |
---|---|
author | Vaas, Sebastian Zimmermann, Markus O. Schollmeyer, Dieter Stahlecker, Jason Engelhardt, Marc U. Rheinganz, Janosch Drotleff, Bernhard Olfert, Matthias Lämmerhofer, Michael Kramer, Markus Stehle, Thilo Boeckler, Frank M. |
author_facet | Vaas, Sebastian Zimmermann, Markus O. Schollmeyer, Dieter Stahlecker, Jason Engelhardt, Marc U. Rheinganz, Janosch Drotleff, Bernhard Olfert, Matthias Lämmerhofer, Michael Kramer, Markus Stehle, Thilo Boeckler, Frank M. |
author_sort | Vaas, Sebastian |
collection | PubMed |
description | [Image: see text] As an orthogonal principle to the established (hetero)aryl halides, we herein highlight the usefulness of CF(2)X (X = Cl, Br, or I) moieties. Using tool compounds bearing CF(2)X moieties, we study their chemical/metabolic stability and their logP/solubility, as well as the role of XB in their small molecular crystal structures. Employing QM techniques, we analyze the observed interactions, provide insights into the conformational flexibilities and preferences in the potential interaction space. For their application in molecular design, we characterize their XB donor capacities and its interaction strength dependent on geometric parameters. Implementation of CF(2)X acetamides into our HEFLibs and biophysical evaluation (STD-NMR/ITC), followed by X-ray analysis, reveals a highly interesting binding mode for fragment 23 in JNK3, featuring an XB of CF(2)Br toward the P-loop, as well as chalcogen bonds. We suggest that underexplored chemical space combined with unconventional binding modes provides excellent opportunities for patentable chemotypes for therapeutic intervention. |
format | Online Article Text |
id | pubmed-10424184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104241842023-08-15 Principles and Applications of CF(2)X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery Vaas, Sebastian Zimmermann, Markus O. Schollmeyer, Dieter Stahlecker, Jason Engelhardt, Marc U. Rheinganz, Janosch Drotleff, Bernhard Olfert, Matthias Lämmerhofer, Michael Kramer, Markus Stehle, Thilo Boeckler, Frank M. J Med Chem [Image: see text] As an orthogonal principle to the established (hetero)aryl halides, we herein highlight the usefulness of CF(2)X (X = Cl, Br, or I) moieties. Using tool compounds bearing CF(2)X moieties, we study their chemical/metabolic stability and their logP/solubility, as well as the role of XB in their small molecular crystal structures. Employing QM techniques, we analyze the observed interactions, provide insights into the conformational flexibilities and preferences in the potential interaction space. For their application in molecular design, we characterize their XB donor capacities and its interaction strength dependent on geometric parameters. Implementation of CF(2)X acetamides into our HEFLibs and biophysical evaluation (STD-NMR/ITC), followed by X-ray analysis, reveals a highly interesting binding mode for fragment 23 in JNK3, featuring an XB of CF(2)Br toward the P-loop, as well as chalcogen bonds. We suggest that underexplored chemical space combined with unconventional binding modes provides excellent opportunities for patentable chemotypes for therapeutic intervention. American Chemical Society 2023-07-24 /pmc/articles/PMC10424184/ /pubmed/37487500 http://dx.doi.org/10.1021/acs.jmedchem.3c00634 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Vaas, Sebastian Zimmermann, Markus O. Schollmeyer, Dieter Stahlecker, Jason Engelhardt, Marc U. Rheinganz, Janosch Drotleff, Bernhard Olfert, Matthias Lämmerhofer, Michael Kramer, Markus Stehle, Thilo Boeckler, Frank M. Principles and Applications of CF(2)X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery |
title | Principles
and Applications of CF(2)X Moieties
as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical
Biology, and Drug Discovery |
title_full | Principles
and Applications of CF(2)X Moieties
as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical
Biology, and Drug Discovery |
title_fullStr | Principles
and Applications of CF(2)X Moieties
as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical
Biology, and Drug Discovery |
title_full_unstemmed | Principles
and Applications of CF(2)X Moieties
as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical
Biology, and Drug Discovery |
title_short | Principles
and Applications of CF(2)X Moieties
as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical
Biology, and Drug Discovery |
title_sort | principles
and applications of cf(2)x moieties
as unconventional halogen bond donors in medicinal chemistry, chemical
biology, and drug discovery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424184/ https://www.ncbi.nlm.nih.gov/pubmed/37487500 http://dx.doi.org/10.1021/acs.jmedchem.3c00634 |
work_keys_str_mv | AT vaassebastian principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT zimmermannmarkuso principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT schollmeyerdieter principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT stahleckerjason principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT engelhardtmarcu principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT rheinganzjanosch principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT drotleffbernhard principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT olfertmatthias principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT lammerhofermichael principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT kramermarkus principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT stehlethilo principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery AT boecklerfrankm principlesandapplicationsofcf2xmoietiesasunconventionalhalogenbonddonorsinmedicinalchemistrychemicalbiologyanddrugdiscovery |